Allan Marshall Purchases 50,000 Shares of Upexi (NASDAQ:UPXI) Stock

Upexi, Inc. (NASDAQ:UPXI) CEO Allan Marshall purchased 50,000 shares of the firm’s stock in a transaction on Tuesday, December 16th. The shares were acquired at an average price of $2.07 per share, with a total value of $103,500.00. Following the completion of the acquisition, the chief executive officer owned 3,996,261 shares in the company, valued at approximately $8,272,260.27. This trade represents a 1.27% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Allan Marshall also recently made the following trade(s):

• On Monday, December 15th, Allan Marshall acquired 100,000 shares of Upexi stock. The stock was acquired at an average cost of $2.07 per share, for a total transaction of $207,000.00.

Upexi Stock Up 0.5%

Shares of Upexi stock opened at $1.88 on Friday. The stock’s 50-day moving average is $3.59 and its 200 day moving average is $5.70. Upexi, Inc. has a one year low of $1.86 and a one year high of $22.57. The firm has a market cap of $118.83 million, a price-to-earnings ratio of -0.44 and a beta of -0.52. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.41 and a quick ratio of 3.39.

Upexi (NASDAQ:UPXI) last issued its earnings results on Wednesday, November 12th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.11). The business had revenue of $9.24 million during the quarter, compared to the consensus estimate of $7.33 million. Upexi had a negative return on equity of 30.42% and a net margin of 264.25%.

Upexi announced that its board has authorized a stock repurchase plan on Thursday, November 13th that authorizes the company to repurchase $50.00 million in shares. This repurchase authorization authorizes the company to buy up to 25.1% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

Institutional Trading of Upexi

Several hedge funds have recently bought and sold shares of the business. Ameritas Advisory Services LLC bought a new stake in Upexi during the 3rd quarter valued at $26,000. Belpointe Asset Management LLC acquired a new position in shares of Upexi during the third quarter valued at about $58,000. Arkadios Wealth Advisors bought a new stake in shares of Upexi during the third quarter worth about $58,000. GSA Capital Partners LLP bought a new stake in shares of Upexi during the third quarter worth about $66,000. Finally, Bank of America Corp DE raised its holdings in shares of Upexi by 3,733.8% in the 3rd quarter. Bank of America Corp DE now owns 13,725 shares of the company’s stock worth $79,000 after acquiring an additional 13,367 shares during the last quarter. Institutional investors and hedge funds own 5.68% of the company’s stock.

Wall Street Analysts Forecast Growth

UPXI has been the topic of several research analyst reports. Cantor Fitzgerald cut their target price on shares of Upexi from $16.00 to $6.00 and set an “overweight” rating on the stock in a research note on Friday, November 14th. Wall Street Zen upgraded shares of Upexi from a “sell” rating to a “hold” rating in a report on Tuesday. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Upexi in a research report on Monday. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $10.50.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.